Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
11/24/2020
Innovent Granted New Indication Approval for Adalimumab Biosimilar in ...
11/24/2020
SMEI Releases H1/2020 Chinese Drug Market Data by Terminals and Segmen...
11/24/2020
Snapshot of Urban Chinese Retail Pharmacy Chemical Drug Sales in H1/20...
11/24/2020
Snapshot of Urban Chinese Public Medical Institution Chemical Drug Sal...
11/24/2020
JD Health to Raise $3.5 Billion in Asia's Biggest Health IPO
11/24/2020
JD Health and CTTQ Sign Pharma e-Commerce Alliance Deal
11/24/2020
Basilea and Pfizer Files NDA for Antifungal Cresemba in China
11/23/2020
NHSA Issues New Documents on Diagnosis-Intervention Packet Payment
11/23/2020
Snapshot of R&D Spending by A and H Share-Listed Chinese MedPharm Cos ...
11/20/2020
Amgen's XGEVA (Denosumab) Approved in China for SREs and MM
11/20/2020
NHSA Issues Two Drug Price and Tender Purchase Credit Rating Documents
11/20/2020
Recent Executive Moves
11/19/2020
Viatris Outlook Clouded by China and Japan Business Prospects
11/19/2020
Chinese Pharma Outsourcing Industry Witness Sharp Growth in 3Qs/2020
11/19/2020
MSD Files NDA for Antiviral Prevymis (Letermovir) in China
11/19/2020
WuXi Advanced Therapies Expands Philadelphia Campus with New State-of-...
11/19/2020
Wanbangde Pharma Fined CNY 2.5M for Abuse of Market Monopoly
11/18/2020
Bloomberg: Pfizer Seeks Deals With Chinese Biotechs to Offset Lost Rev...
11/18/2020
WSJ: Chinese Covid Vaccine Gives Scientists Pause Over Antibody Levels...
11/18/2020
Contract Pharma: Bye-Bye China?
11/16/2020
Merck and Transcenta Collaborate to Advance Continuous Biomanufacturin...
11/16/2020
Tracon Pharma Files NDA for Anticancer Envafolimab in China
11/13/2020
Recent Executive Moves
11/13/2020
What to Expect in China's 14th Five Year Plan? Decoding the Fifth Plen...
11/12/2020
NMPA Solicits Comments on Draft Provisions for Supervision and Adminis...
11/12/2020
Apollomics Granted IND Approval for APL-102 to Initiate a Phase 1 Stud...
11/12/2020
Takeda, OrigiMed to Develop Genomic-based Clinical Treatment Platform
11/11/2020
SAMR Releases Draft Anti-Monopoly Rules To Scrutinize Online Platforms...
11/11/2020
NHSA Concludes Product Adjustment Evaluation of 2020 NDRL
11/11/2020
Pfizer Inks Deal with Dynamiker
Page:
106
/
360
Total number of articles:
10791
:
[First]
[<<]
[104]
[105]
[106]
[107]
[108]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit